Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Otsuka Holdings Co. Ltd. (OTC: OTSKF).

Full DD Report for OTSKF

You must become a subscriber to view this report.


Recent News from (OTC: OTSKF)

Lundbeck and Otsuka's combo treatment for PTSD successful in mid-stage study
Otsuka Pharmaceutical Company ( OTCPK:OTSKF )( OTCPK:OTSKY ) and development partner H. Lundbeck A/S ( OTC:HLUKF )( OTCPK:HLUYY ) announce positive results from a Phase 2 clinical trial evaluating the combination of brexpiprazole and Pfizer's ( PFE +0.7% ) Zoloft (sertraline HCl) for t...
Source: SeekingAlpha
Date: November, 30 2018 09:55
3 Things In Biotech, August 2: Japanese Drug Makers Rise And Fall
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. Otsuka failure portends termination of an important AML study Company: Otsuka ( OTCPK:O...
Source: SeekingAlpha
Date: August, 02 2018 08:00
Otsuka Holdings Co. Ltd. ADR 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Otsuka Holdings Co. Ltd. ADR in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 14 2018 14:08
FDA OKs Otsuka's tolvaptan to slow kidney function decline in inherited kidney cyst disorder
The FDA approves Otsuka Pharmaceutical's ( OTCPK:OTSKF )( OTCPK:OTSKY ) JYNARQUE (tolvaptan) to slow the decline in kidney function in patients with rapidly progressing autosomal dominant polycystic kidney disease (ADPKD), an inherited disorder characterized by the formation of cysts i...
Source: SeekingAlpha
Date: April, 24 2018 15:34
Otsuka teams up with X-Chem in drug discovery
Otsuka Holdings ( OTCPK:OTSKF )( OTCPK:OTSKY ) unit Otsuka Pharmaceutical inks an agreement with privately held X-Chem aimed at advancing Otsuka drug compounds. More news on: Otsuka Holdings Co. Ltd., Otsuka Holdings Co. Ltd. ADR, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: December, 19 2017 16:10
Otsuka bails on Sativex, returns rights to GW Pharma
GW Pharmaceuticals ( GWPH +0.7% ) and Otsuka Pharmaceutical ( OTCPK:OTSKF )( OTCPK:OTSKY ) terminate their license agreement for cannabinoid Sativex (nabiximols), returning the U.S. rights to GW who has agreed to pay Otsuka milestone payments upon FDA approval and the achievement of cert...
Source: SeekingAlpha
Date: December, 13 2017 10:29
U.S. Regulators Approve Digital Pill That Tracks When People Take It
That’s one small step for man, one giant leap for healthcare and technology. On Tuesday, the FDA announced that it has approved the first digital pill that has a sensor to track if patients are taking their medication properly. Essentially, the digital pill is a version of Otsuka Pharma...
Source: StreetSignals
Date: November, 14 2017 16:30
Your Daily Pharma Scoop: Teva Q3 Results, Boost For RedHill, Clovis Reports Rubraca Sales
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Please click here or scroll down below to read an important announcement about chan...
Source: SeekingAlpha
Date: November, 02 2017 09:42

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A48.10N/AN/A0
2018-12-13N/A48.10N/AN/A0
2018-12-12N/A48.10N/AN/A0
2018-12-11N/A48.10N/AN/A0
2018-12-10N/A48.10N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-23218218100.0000Short
2018-11-211010100.0000Short
2018-11-1988100.0000Short
2018-11-1520028171.1744Short
2018-11-1431541575.9036Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on OTSKF.


About Otsuka Holdings Co. Ltd. (OTC: OTSKF)

Logo for Otsuka Holdings Co. Ltd. (OTC: OTSKF)

Not available

 

Contact Information

 

 

Current Management

  • Tatsuo Higuchi / President, CEO

Current Share Structure

  • Market Cap: $27,713,272,608 - 03/12/2018
  • Issue and Outstanding: 557,835,600 - 11/30/2011

 


Recent Filings from (OTC: OTSKF)

Post-effective amendment to a previously filed F-6
Filing Type: F-6 POSFiling Source: edgar
Filing Date: September, 29 2017

 

 


Daily Technical Chart for (OTC: OTSKF)

Daily Technical Chart for (OTC: OTSKF)


Stay tuned for daily updates and more on (OTC: OTSKF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: OTSKF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OTSKF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of OTSKF and does not buy, sell, or trade any shares of OTSKF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/